SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 50.67 |
Enterprise Value ($M) | 45.75 |
Book Value ($M) | -13.05 |
Book Value / Share | -0.37 |
Price / Book | -3.88 |
NCAV ($M) | -13.05 |
NCAV / Share | -0.37 |
Price / NCAV | -3.88 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -8.79 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.29 |
Current Ratio | 0.29 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.38 |
Assets | 5.38 |
Liabilities | 18.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.10 |
Operating Income | -52.15 |
Net Income | -51.85 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -47.59 |
Cash from Investing | 0.00 |
Cash from Financing | 40.45 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Fortress Biotech, Inc. | 7.50 | 14.40 | |
13G/A | Armistice Capital, Llc | 9.99 | 175.08 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
136,412 | 520,083 | 26.23 | |
40,043 | 166,058 | 24.11 | |
61,757 | 24,637 | 250.67 | |
61,903 | 114,451 | 54.09 | |
106,121 | 83,373 | 127.28 | |
(click for more detail) |
Similar Companies | |
---|---|
CERE – Cerevel Therapeutics Holdings, Inc. | CGEN – Compugen Ltd. |
CING – Cingulate Inc. | CLDX – Celldex Therapeutics, Inc. |
CLNN – Clene Inc. |
Financial data and stock pages provided by
Fintel.io